Correo

U.S. markets closed

S&P 500
5,303.27
+6.17(+0.12%)
Dow Jones
40,003.59
+134.21(+0.34%)
Nasdaq
16,685.97
-12.35(-0.07%)
Russell 2000
2,095.72
-0.53(-0.03%)
Petróleo
80.00
+0.77(+0.97%)
Oro
2,419.80
+34.30(+1.44%)

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD.

Añadir a la lista de seguimiento

1.1900

+0.0100

(+0.85%)

Al cierre: 04:00PM EDT

1.1800

-0.01

(-0.84%)

Fuera de horario:

04:03PM EDT

Accionistas principales

Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Nómina de miembros de la gerencia

Persona o entidad	Transacción más reciente	Fecha	Acciones adquiridas a partir de la fecha de transacción
BALTHASER KEVIN J Chief Financial Officer	Conversion of Exercise of derivative security	29 feb 2024	23,983
CAWKWELL GAIL Officer	Conversion of Exercise of derivative security	29 jun 2023	9,593
LOEROP JAMES Officer	Conversion of Exercise of derivative security	31 ene 2024	34,017
MANION DOUGLAS J Chief Executive Officer	Conversion of Exercise of derivative security	28 dic 2023	41,813
MILANO VINCENT J Director	Conversion of Exercise of derivative security	01 jun 2023	7,863
MOLINEAUX CHRISTOPHER P Director	Conversion of Exercise of derivative security	19 jun 2023	48,503
MONAHAN JOSEPH B Officer	Conversion of Exercise of derivative security	29 feb 2024	186,976
POWELL ANDREW KENNETH WILLIAM Director	Purchase	03 mar 2024	28,863
SCHIFF ANDREW N Director	Conversion of Exercise of derivative security	01 jun 2023	438,962
WALKER NEAL Chief Executive Officer	Conversion of Exercise of derivative security	30 abr 2024	1,292,370
*La lista miembros de la gerencia se deriva únicamente de los últimos 24 meses de las presentaciones SEC de las Planillas 3 y 4.